{"id":1018624,"date":"2026-11-09T07:27:09","date_gmt":"2026-11-09T12:27:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/"},"modified":"2026-11-09T07:27:09","modified_gmt":"2026-11-09T12:27:09","slug":"immunocore-to-present-at-upcoming-investor-conferences-11","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/","title":{"rendered":"Immunocore to present at upcoming investor conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>(OXFORDSHIRE, England &amp; RADNOR, PA &amp; GAITHERSBURG, MD, US, 09 November 2026)\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gOngGrpzS_wUBRLs-j8n9afEdZpkqvGYi4-odqGrWxYewyx_sP_ZTI2t4TPz-Nmczkzf0oBSFztY4H68qhdLuFTeIjQOAgTkwod8D7JnZOok6sengikvhKsPaJDVjJdOYf0qEiQI9OAg4708X2uZlMZkmLm4L38YanlrqH-hRLlHsMvmg_7v2duNxHz0bmrm\" rel=\"nofollow\" target=\"_blank\">Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d)<\/a>, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in November.<\/p>\n<p align=\"justify\">\n        <b>UBS Global Biopharma Conference 2026<\/b><br \/>\n        <br \/>Fireside Chat: Tuesday, November 17, 2026, at 3:20 p.m. GMT<\/p>\n<p align=\"justify\">\n        <b>Jefferies London Global Healthcare Conference <\/b><br \/>\n        <br \/>1&#215;1 and small group meetings: Wednesday, November 18, 2026<\/p>\n<p>The presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay of the presentation will be made available for a limited time.<\/p>\n<p>\n        <b>About Immunocore<\/b>\n      <\/p>\n<p>Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX \u2013 Immune mobilizing monoclonal TCRs Against X disease \u2013 designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including clinical and pre-clinical programs\u200b in oncology, infectious diseases, and autoimmune diseases. The Company\u2019s most advanced oncology TCR therapeutic, KIMMTRAK, has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in 39 countries, including the United States, European Union, Canada, Australia, and the United Kingdom.<\/p>\n<p>\n        <b>Contact Information<\/b>\n      <\/p>\n<p>\n        <b>Immunocore <\/b>\n      <\/p>\n<p>S\u00e9bastien Desprez, Vice President Communications<br \/>T: +44 (0) 7458030732<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-0ajI0st8cdCAY4TOEMN8-dD9KT4E_gUQexNaMC1n6rDGyguthwjKAsVfw7CWltE7ASO0zg8QSXeZeU12p9Inz4UkUcZJPBVl0K6P0GTwY-dyDNMuFPFxa-XE3dFiQ3JcQGSX3torqJXaNfJYCtiXg==\" rel=\"nofollow\" target=\"_blank\"><u>sebastien.desprez@immunocore.com<\/u><\/a><br \/>Follow on LinkedIn: @Immunocore<\/p>\n<p>Ryan Baker, Vice President of Investor Relations<br \/>T: +1 (215) 384-4781<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XI6cGGWhx_-d_PU9Rn-E4SCIX4lhb0Qwas_20f6w8P4NGle0bk0BbaltQHmWu-tit0ZbdmkAnfs1B7slhVZAf7qxuDJnK5Hl4tzJgBw6ezE=\" rel=\"nofollow\" target=\"_blank\"><u>ir@immunocore.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MmNmOGRmYTgtOTY4Ny00ODRhLWJmMDktMTA0Nzk3ZmI1NDhkLTEyMTc4MTEtMjAyNi0xMS0wOS1lbg==\/tiny\/Immunocore-Holdings-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>(OXFORDSHIRE, England &amp; RADNOR, PA &amp; GAITHERSBURG, MD, US, 09 November 2026)\u00a0Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in November. UBS Global Biopharma Conference 2026 Fireside Chat: Tuesday, November 17, 2026, at 3:20 p.m. GMT Jefferies London Global Healthcare Conference 1&#215;1 and small group meetings: Wednesday, November 18, 2026 The presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay of the presentation will be made &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Immunocore to present at upcoming investor conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1018624","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunocore to present at upcoming investor conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunocore to present at upcoming investor conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"(OXFORDSHIRE, England &amp; RADNOR, PA &amp; GAITHERSBURG, MD, US, 09 November 2026)\u00a0Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in November. UBS Global Biopharma Conference 2026 Fireside Chat: Tuesday, November 17, 2026, at 3:20 p.m. GMT Jefferies London Global Healthcare Conference 1&#215;1 and small group meetings: Wednesday, November 18, 2026 The presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay of the presentation will be made &hellip; Continue reading &quot;Immunocore to present at upcoming investor conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T12:27:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Immunocore to present at upcoming investor conferences\",\"datePublished\":\"2026-11-09T12:27:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/\",\"name\":\"Immunocore to present at upcoming investor conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==\",\"datePublished\":\"2026-11-09T12:27:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-11\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunocore to present at upcoming investor conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunocore to present at upcoming investor conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/","og_locale":"en_US","og_type":"article","og_title":"Immunocore to present at upcoming investor conferences - Market Newsdesk","og_description":"(OXFORDSHIRE, England &amp; RADNOR, PA &amp; GAITHERSBURG, MD, US, 09 November 2026)\u00a0Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in November. UBS Global Biopharma Conference 2026 Fireside Chat: Tuesday, November 17, 2026, at 3:20 p.m. GMT Jefferies London Global Healthcare Conference 1&#215;1 and small group meetings: Wednesday, November 18, 2026 The presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay of the presentation will be made &hellip; Continue reading \"Immunocore to present at upcoming investor conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-09T12:27:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Immunocore to present at upcoming investor conferences","datePublished":"2026-11-09T12:27:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/","name":"Immunocore to present at upcoming investor conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==","datePublished":"2026-11-09T12:27:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTIyOSM0MDI1NTcwOTQjMjIwNjI1OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-11\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Immunocore to present at upcoming investor conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1018624"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018624\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1018624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1018624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1018624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}